CochLear Ltd ADR (CHEOY)
Cochlear Ltd ADR is a depositary receipt listed on OTC Markets that represents common stock in Cochlear Limited. The underlying issuer develops implantable hearing solutions for children and adults, with offerings that include cochlear implant systems, sound processor upgrades, bone conduction systems, and related accessories. Its product range also covers Nucleus sound processors and implants, a smart bimodal hearing solution, and Baha systems such as the Baha 6 Max sound processor and Baha implant, along with wireless and water-safe accessories. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CHEO.Y
|
$58.79
|
17.4% Upside
|
Fair
|
Not available
|
Not available
|
Good
|
2.2%
|
November 9, 2026
|
62.6x
|
5.3x
|
3.9x
|
6.567 B
|
6.402 B
|
2.3%
|
99.6%
|
9.9
|
190.9%
|
208.4%
|
